These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18068866)

  • 1. Hematopoietic cell transplantation for hemoglobinopathies.
    Krishnamurti L; Bunn HF; Williams AM; Tolar J
    Curr Probl Pediatr Adolesc Health Care; 2008 Jan; 38(1):6-18. PubMed ID: 18068866
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending Gene Medicines to All in Need.
    McCune JM; Kiem HP
    N Engl J Med; 2024 May; 390(18):1721-1722. PubMed ID: 38657269
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease.
    Leonard A; Tisdale JF; Bonner M
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):769-795. PubMed ID: 35773052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy.
    Hayashi S; Abdulmalik O; Peranteau WH; Ashizuka S; Campagnoli C; Chen Q; Horiuchi K; Asakura T; Flake AW
    Exp Hematol; 2003 Feb; 31(2):176-84. PubMed ID: 12591283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
    Al Jefri AH
    Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
    Payen E; Leboulch P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy for Hemoglobinopathies.
    Lidonnici MR; Scaramuzza S; Ferrari G
    Hum Gene Ther; 2023 Sep; 34(17-18):793-807. PubMed ID: 37675899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing for the β-Hemoglobinopathies.
    Porteus MH
    Adv Exp Med Biol; 2017; 1013():203-217. PubMed ID: 29127682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassemia and related hemoglobinopathies.
    Sarnaik SA
    Indian J Pediatr; 2005 Apr; 72(4):319-24. PubMed ID: 15876761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials.
    Segura EER; Ayoub PG; Hart KL; Kohn DB
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.
    Andreani M; Testi M; Gaziev J; Condello R; Bontadini A; Tazzari PL; Ricci F; De Felice L; Agostini F; Fraboni D; Ferrari G; Battarra M; Troiano M; Sodani P; Lucarelli G
    Haematologica; 2011 Jan; 96(1):128-33. PubMed ID: 20935000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies.
    Kharya G; Bakane AN; Rauthan AM
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28909. PubMed ID: 33470527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero transplantation for thalassemia.
    Flake AW; Zanjani ED
    Ann N Y Acad Sci; 1998 Jun; 850():300-11. PubMed ID: 9668552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.